[1]
|
Zhang, G. and Pradhan, S. (2014) Mammalian Epigenetic Mechanisms. IUBMB Life, 66, 240-256.
https://doi.org/10.1002/iub.1264
|
[2]
|
Pal, S. and Sif, S. (2007) Interplay between Chromatin Remodelers and Pro-tein Arginine Methyltransferases. Journal of Cellular Physiology, 213, 306-315. https://doi.org/10.1002/jcp.21180
|
[3]
|
Lin, W., Gary, J.D., Yang, M.C., et al. (1996) The Mammalian Immedi-ate-Early TIS21 Protein and the Leukemia-Associated BTG1 Protein Interact with a Protein-Arginine N-Methyltransferase. Journal of Biological Chemistry, 271, 15034-15044. https://doi.org/10.1074/jbc.271.25.15034
|
[4]
|
Bannister, A.J. and Kouzarides, T. (2011) Regulation of Chromatin by Histone Modifications. Cell Research, 21, 381-395. https://doi.org/10.1038/cr.2011.22
|
[5]
|
Hu, H., Qian, K., Zheng, Y.G., et al. (2016) Small Molecule Inhibitors of Protein Arginine Methyltransferases. Expert Opinion on Investi-gational Drugs, 25, 335-358. https://doi.org/10.1517/13543784.2016.1144747
|
[6]
|
Krause, C.D., Yang, Z.H., Kim, Y.S., et al. (2007) Protein Arginine Methyltransferases: Evolution and Assessment of Their Pharmacological and Therapeutic Potential. Pharmacology & Therapeutics, 113, 50-87.
https://doi.org/10.1016/j.pharmthera.2006.06.007
|
[7]
|
Hadjikyriacou, A., Yang, Y.Z., Espejo, A., et al. (2015) Unique Features of Human Protein Arginine Methyltransferase 9 (PRMT9) and Its Substrate RNA Splicing Factor SF3B2. Journal of Biological Chemistry, 290, 16723-16743.
https://doi.org/10.1074/jbc.M115.659433
|
[8]
|
Qi, C., Chang, J., Zhu, Y.W., et al. (2002) Identification of Protein Arginine Methyltransferase 2 as a Coactivator for Estrogen Receptor Alpha. Journal of Biological Chemistry, 277, 28624-28630.
https://doi.org/10.1074/jbc.M201053200
|
[9]
|
Bachand, F. and Silver, P.A. (2004) PRMT3 Is a Ribosomal Protein Methyltransferase That Affects the Cellular Levels of Ribosomal Subunits. The EMBO Journal, 23, 2641-2650. https://doi.org/10.1038/sj.emboj.7600265
|
[10]
|
Naeem, H., Cheng, D.H., Zhao, Q.S., et al. (2007) The Activity and Stability of the Transcriptional Coactivator p/CIP/SRC-3 Are Regulated by CARM1-Dependent Methylation. Molecular and Cellular Biology, 27, 120-134.
https://doi.org/10.1128/MCB.00815-06
|
[11]
|
Wilczek, C., Chitta, R., Woo, E., et al. (2011) Protein Arginine Me-thyltransferase Prmt5-Mep50 Methylates Histones H2A and H4 and the Histone Chaperone Nucleoplasmin in Xenopus laevis Eggs. Journal of Biological Chemistry, 286, 42221-42231. https://doi.org/10.1074/jbc.M111.303677
|
[12]
|
Bedford, M.T. (2007) Arginine Methylation at a Glance. Journal of Cell Science, 120, 4243-4246.
https://doi.org/10.1242/jcs.019885
|
[13]
|
Tewary, S.K., Zheng, Y.G. and Ho, M.C. (2019) Protein Arginine Methyl-transferases: Insights into the Enzyme Structure and Mechanism at the Atomic Level. Cellular and Molecular Life Sci-ences, 76, 2917-2932.
https://doi.org/10.1007/s00018-019-03145-x
|
[14]
|
Pawlak, M.R., Scherer, C.A., Chen, J., et al. (2000) Arginine N-methyltransferase 1 Is Required for Early Post-Implantation Mouse Development, but Cells Deficient in the Enzyme Are Viable. Molecular and Cellular Biology, 20, 4859-4869. https://doi.org/10.1128/MCB.20.13.4859-4869.2000
|
[15]
|
Thiebaut, C., Eve, L., Poulard, C., et al. (2021) Structure, Activity, and Function of PRMT1. Life, 11, 1147.
https://doi.org/10.3390/life11111147
|
[16]
|
Côté, J., Boisvert, F.M., Boulanger, M.C., et al. (2003) Sam68 RNA Binding Protein Is an in Vivo Substrate for Protein Arginine N-methyltransferase 1. Molecular Biology of the Cell, 14, 274-287. https://doi.org/10.1091/mbc.e02-08-0484
|
[17]
|
Déry, U., Coulombe, Y., Rodrigue, A., et al. (2008) A Glycine-Arginine Domain in Control of the Human MRE11 DNA Repair Protein. Molecular and Cellular Biology, 28, 3058. https://doi.org/10.1128/MCB.02025-07
|
[18]
|
Le Romancer, M., Treilleux, I., Leconte, N., et al. (2008) Regu-lation of Estrogen Rapid Signaling through Arginine Methylation by PRMT1. Molecular Cell, 31, 212-221. https://doi.org/10.1016/j.molcel.2008.05.025
|
[19]
|
Liu, M., Hua, W., Chen, C., et al. (2020) The MKK-Dependent Phosphorylation of p38α Is Augmented by Arginine Methylation on arg49/arg149 during Erythroid Differentiation. In-ternational Journal of Molecular Sciences, 21, 3546.
https://doi.org/10.3390/ijms21103546
|
[20]
|
Mathioudaki, K., Scorilas, A., Ardavanis, A., et al. (2011) Clinical Evaluation of PRMT1 Gene Expression in Breast Cancer. Tumor Biology, 32, 575-582. https://doi.org/10.1007/s13277-010-0153-2
|
[21]
|
Poulard, C., Treilleux, I., Lavergne, E., et al. (2012) Activation of Rapid Oestrogen Signalling in Aggressive Human Breast Cancer. EMBO Molecular Medicine, 4, 1200-1213. https://doi.org/10.1002/emmm.201201615
|
[22]
|
Nakai, K., Xia, W., Liao, H., et al. (2018) The Role of PRMT1 in EGFR Methylation and Signaling in MDA-MB-468 Triple-Negative Breast Cancer Cells. Breast Cancer, 25, 74-80. https://doi.org/10.1007/s12282-017-0790-z
|
[23]
|
Liu, L.M., Sun, W.Z., Fan, X.Z., et al. (2019) Methylation of C/EBPa by PRMT1 Inhibits Its Tumor-Suppressive Function in Breast Cancer. Cancer Research, 79, 2865-2877. https://doi.org/10.1158/0008-5472.CAN-18-3211
|
[24]
|
Mathioudaki, K., Papadokostopoulou, A., Scorilas, A., et al. (2008) The PRMT1 Gene Expression Pattern in Colon Cancer. British Journal of Cancer, 99, 2094-2099. https://doi.org/10.1038/sj.bjc.6604807
|
[25]
|
Yao, B., Gui, T., Zeng, X., et al. (2021) PRMT1-Mediated H4R3me2a Recruits SMARCA4 to Promote Colorectal Cancer Progression by Enhancing EGFR Signaling. Genome Medicine, 13, 1-21.
https://doi.org/10.1186/s13073-021-00871-5
|
[26]
|
Liao, H.W., Hsu, J.M., Xia, W., et al. (2015) PRMT1-Mediated Methylation of the EGF Receptor Regulates Signaling and Cetuximab Response. Journal of Clinical Investigation, 125, 4529-4543. https://doi.org/10.1172/JCI82826
|
[27]
|
Elakoum, R., Gauchotte, G., Oussalah, A., et al. (2014) CARM1 and PRMT1 Are Dysregulated in Lung Cancer without Hierarchical Features. Biochimie, 97, 210-218. https://doi.org/10.1016/j.biochi.2013.10.021
|
[28]
|
Avasarala, S., Van Scoyk, M., Kumar, M., et al. (2015) PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-Small Cell Lung Cancer. Journal of Biological Chemistry, 290, 13479-13489.
https://doi.org/10.1074/jbc.M114.636050
|
[29]
|
Lin, Z.B., Chen, Y., Lin, Z.X., et al. (2018) Overexpressing PRMT1 Inhibits Proliferation and Invasion in Pancreatic Cancer by Inverse Correlation of ZEB1. IUBMB Life, 70, 1032-1039. https://doi.org/10.1002/iub.1917
|
[30]
|
Chuang, C.Y., Chang, C.P., Lee, Y.J., et al. (2017) PRMT1 Ex-pression Is Elevated in Head and Neck Cancer and Inhibition of Protein Arginine Methylation by Adenosine Dialdehyde or PRMT1 Knockdown Downregulates Proliferation and Migration of Oral Cancer Cells. Oncology Reports, 38, 1115-1123. https://doi.org/10.3892/or.2017.5737
|
[31]
|
Zhang, Y.L., Wang, D.W., Zhang, M.T., et al. (2018) Pro-tein Arginine Methyltransferase 1 Coordinates the Epithelial-Mesenchymal Transition/Proliferation Dichotomy in Gastric Cancer Cells. Experimental Cell Research, 362, 43-50.
https://doi.org/10.1016/j.yexcr.2017.10.035
|
[32]
|
Lee, Y.J., Chang, W.W., Chang, C.P., et al. (2019) Downregula-tion of PRMT1 Promotes the Senescence and Migration of a Non-MYCN Amplified Neuroblastoma SK-N-SH Cells. Scientific Reports, 9, Article No. 1771.
https://doi.org/10.1038/s41598-018-38394-6
|
[33]
|
Cheng, D., Yadav, N., King, R.W., et al. (2004) Small Molecule Regulators of Protein Arginine Methyltransferases. Journal of Biological Chemistry, 279, 23892-23899. https://doi.org/10.1074/jbc.M401853200
|
[34]
|
Spannhoff, A., Heinke, R., Jung, M., et al. (2007) Target-Based Approach to Inhibitors of Histone Arginine Methyltransferases. Journal of Medicinal Chemistry, 50, 2319-2325. https://doi.org/10.1021/jm061250e
|
[35]
|
Sun, Q., Liu, L., Roth, M., et al. (2015) PRMT1 Upregulated by Epithelial Proinflammatory Cytokines Participates in COX2 Expression in Fibroblasts and Chronic Antigen-Induced Pulmonary Inflammation. The Journal of Immunology, 195, 298-306. https://doi.org/10.4049/jimmunol.1402465
|
[36]
|
Eram, M.S., Shen, Y.D., Szewczyk, M.M., et al. (2016) A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases. ACS Chemical Biology, 11, 772-781.
https://doi.org/10.1021/acschembio.5b00839
|
[37]
|
Zhu, Y.H., He, X., Dong, H.J., et al. (2019) Targeting PRMT1-Mediated FLT3 Methylation Disrupts Maintenance of MLL-Rearranged Acute Lymphoblastic Leukemia. Blood, 134, 1257-1268. https://doi.org/10.1182/blood.2019002457
|
[38]
|
He, X., Zhu, Y.H., Lin, Y.C., et al. (2019) PRMT1-Mediated FLT3 Arginine Methylation Promotes Maintenance of FLT3-ITD+ Acute Myeloid Leukemia. Blood, 134, 548-560. https://doi.org/10.1182/blood.2019001282
|
[39]
|
Plotnikov, A., Kozer, N., Cohen, G., et al. (2020) PRMT1 Inhibition Induces Differentiation of Colon Cancer Cells. Scientific Reports, 10, Article No. 20030. https://doi.org/10.1038/s41598-020-77028-8
|
[40]
|
Al-Hamashi, A.A., Chen, D., Deng, Y., et al. (2021) Discovery of a Potent and Dual-Selective Bisubstrate Inhibitor for Protein Arginine Methyltransferase 4/5. Acta Pharmaceutica Sinica B, 11, 2709-2718.
https://doi.org/10.1016/j.apsb.2020.10.013
|
[41]
|
Iyamu, I.D., Al-Hamashi, A.A. and Huang, R. (2021) A Pan-Inhibitor for Protein Arginine Methyltransferase Family Enzymes. Biomolecules, 11, 854. https://doi.org/10.3390/biom11060854
|
[42]
|
Fedoriw, A., Rajapurkar, S.R., O’Brien, S., et al. (2019) Anti-Tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss. Cancer Cell, 36, 100-114.
https://doi.org/10.1016/j.ccell.2019.05.014
|
[43]
|
Shen, N.Y., Ng, S.Y., Toepp, S.L. and Ljubicic, V. (2018) Protein Arginine Methyltransferase Expression and Activity during Myogenesis. Bioscience Reports, 38, BSR20171533. https://doi.org/10.1042/BSR20171533
|
[44]
|
Kim, E., Jang, J., Park, J.G., et al. (2020) Protein Arginine Methyl-transferase 1 (PRMT1) Selective Inhibitor, TC-E 5003, Has Anti-Inflammatory Properties in TLR4 Signaling. Interna-tional Journal of Molecular Sciences, 21, 3058.
https://doi.org/10.3390/ijms21093058
|
[45]
|
Zhang, P.C., Tao, H., Yu, L.Y., et al. (2020) Developing Protein Argi-nine Methyltransferase 1 (PRMT1) Inhibitor TC-E-5003 as an Antitumor Drug Using INEI Drug Delivery Systems. Drug Delivery, 27, 491-501.
https://doi.org/10.1080/10717544.2020.1745327
|
[46]
|
Heinke, R., Spannhoff, A., Meier, R., et al. (2009) Virtual Screening and Biological Characterization of Novel Histone Arginine Methyltransferase PRMT1 Inhibitors. ChemMedChem, 4, 69-77. https://doi.org/10.1002/cmdc.200800301
|